These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 33520683)

  • 1. Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection.
    Prasansuklab A; Theerasri A; Rangsinth P; Sillapachaiyaporn C; Chuchawankul S; Tencomnao T
    J Tradit Complement Med; 2021 Mar; 11(2):144-157. PubMed ID: 33520683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Malekmohammad K; Rafieian-Kopaei M
    Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.
    Khursheed A; Jain V; Rasool A; Rather MA; Malik NA; Shalla AH
    Microb Pathog; 2021 Aug; 157():104933. PubMed ID: 33984466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents.
    Nandi S; Roy H; Gummadi A; Saxena AK
    Curr Drug Targets; 2021; 22(17):2006-2020. PubMed ID: 33687893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
    Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
    Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An
    Rangsinth P; Sillapachaiyaporn C; Nilkhet S; Tencomnao T; Ung AT; Chuchawankul S
    J Tradit Complement Med; 2021 Mar; 11(2):158-172. PubMed ID: 33520685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation.
    Gorla US; Rao K; Kulandaivelu US; Alavala RR; Panda SP
    Comb Chem High Throughput Screen; 2021; 24(6):879-890. PubMed ID: 32819226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection.
    Goyal RK; Majeed J; Tonk R; Dhobi M; Patel B; Sharma K; Apparsundaram S
    Rev Cardiovasc Med; 2020 Sep; 21(3):365-384. PubMed ID: 33070542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Viral Activity of Bioactive Molecules of Silymarin against COVID-19 via In Silico Studies.
    Zhang C; Sui Y; Liu S; Yang M
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
    Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells.
    Glinsky GV
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32455629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis.
    Bhowmik D; Nandi R; Prakash A; Kumar D
    Heliyon; 2021 Mar; 7(3):e06515. PubMed ID: 33748510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial Metabolites: The Emerging Hotspot of Antiviral Compounds as Potential Candidates to Avert Viral Pandemic Alike COVID-19.
    Raihan T; Rabbee MF; Roy P; Choudhury S; Baek KH; Azad AK
    Front Mol Biosci; 2021; 8():732256. PubMed ID: 34557521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19.
    Wijayasinghe YS; Bhansali P; Viola RE; Kamal MA; Poddar NK
    Curr Pharm Des; 2021; 27(33):3526-3550. PubMed ID: 33213322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Some Antiviral Natural Products to Fight Against Novel Coronavirus (SARS-CoV-2) Using an
    Shah A; Patel V; Parmar B
    Comb Chem High Throughput Screen; 2021; 24(8):1271-1280. PubMed ID: 32881661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between ACE2 and SARS-CoV-2 S Protein: Peptide Inhibitors for Potential Drug Developments Against COVID-19.
    Dërmaku-Sopjani M; Sopjani M
    Curr Protein Pept Sci; 2021; 22(10):729-744. PubMed ID: 34530706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal Plants as Sources of Active Molecules Against COVID-19.
    Benarba B; Pandiella A
    Front Pharmacol; 2020; 11():1189. PubMed ID: 32848790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.